139 related articles for article (PubMed ID: 3828996)
1. Tumor cytokinetics in the presence of normal, alloimmune, or Bacillus Calmette-Guérin-activated host cells simultaneously assayed in vivo and in vitro.
Normann SJ; Cornelius J
Cancer Res; 1987 Apr; 47(8):2067-72. PubMed ID: 3828996
[TBL] [Abstract][Full Text] [Related]
2. Tumoricidal effector mechanisms of murine Bacillus Calmette-Guérin-activated macrophages: mediation of cytolysis, mitochondrial respiration inhibition, and release of intracellular iron by distinct mechanisms.
Klostergaard J; Leroux ME; Ezell SM; Kull FC
Cancer Res; 1987 Apr; 47(8):2014-9. PubMed ID: 3828989
[TBL] [Abstract][Full Text] [Related]
3. Cytokinetics of macrophage-mediated cytotoxicity.
Normann SJ; Cornelius J
Cancer Res; 1984 Jun; 44(6):2313-9. PubMed ID: 6426778
[TBL] [Abstract][Full Text] [Related]
4. Divergent changes in antimicrobial activity after immunologic activation of mouse peritoneal macrophages.
van Dissel JT; Stikkelbroeck JJ; van den Barselaar MT; Sluiter W; Leijh PC; van Furth R
J Immunol; 1987 Sep; 139(5):1665-72. PubMed ID: 2957432
[TBL] [Abstract][Full Text] [Related]
5. [Cytotoxic effect of BCG-activated macrophages on tumor target cells in vitro].
Viadro MM
Biull Eksp Biol Med; 1979 Jan; 87(1):36-9. PubMed ID: 760842
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of bacillus Calmette-Guérin-induced nitric oxide in bladder tumor cells may improve BCG treatment.
Alvarez V; Lodillinsky C; Umerez S; Sandes E; Eiján AM
Int J Mol Med; 2005 Oct; 16(4):565-71. PubMed ID: 16142388
[TBL] [Abstract][Full Text] [Related]
7. Morphological evidence for the translocation of lysosomal organelles from cytotoxic macrophages into the cytoplasm of tumor target cells.
Bucana C; Hoyer LC; Hobbs B; Breesman S; McDaniel M; Hanna MG
Cancer Res; 1976 Dec; 36(12):4444-58. PubMed ID: 187323
[TBL] [Abstract][Full Text] [Related]
8. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
Fidler IJ; Kataoka T; Hanna MG
Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
[TBL] [Abstract][Full Text] [Related]
9. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures.
Ruco LP; Meltzer MS
J Immunol; 1977 Sep; 119(3):889-96. PubMed ID: 330759
[TBL] [Abstract][Full Text] [Related]
10. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
Matsumoto T; Himeno K; Mitani M; Mori K; Miake S; Nomoto K
J Clin Lab Immunol; 1986 Feb; 19(2):83-9. PubMed ID: 3083105
[TBL] [Abstract][Full Text] [Related]
11. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
[TBL] [Abstract][Full Text] [Related]
12. Cytolytic interactions between murine macrophages, tumor cells, and monoclonal antibodies: characterization of lytic conditions and requirements for effector activation.
Johnson WJ; Steplewski Z; Matthews TJ; Hamilton TA; Koprowski H; Adams DO
J Immunol; 1986 Jun; 136(12):4704-13. PubMed ID: 3711663
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of cancer: experimental approach with activated macrophages proliferating in culture.
Bartholeyns J; Lombard Y; Dumont S; Hartmann D; Chokry M; Giaimis J; Kaufmann S; Poindron P
Cancer Detect Prev; 1988; 12(1-6):413-20. PubMed ID: 3180139
[TBL] [Abstract][Full Text] [Related]
14. [Effect of BCG (Bacillus Calmette Guérin) sensitization on the generation of tumor specific killer T cells].
Takeuchi M; Kimoto M; Suzuki I; Nomoto K
Gan To Kagaku Ryoho; 1983 Sep; 10(9):1980-6. PubMed ID: 6604499
[TBL] [Abstract][Full Text] [Related]
15. Significance of target cell infection and natural killer cells in the anti-tumor effects of bacillus Calmette-Guerin in murine bladder cancer.
Sonoda T; Sugimura K; Ikemoto S; Kawashima H; Nakatani T
Oncol Rep; 2007 Jun; 17(6):1469-74. PubMed ID: 17487406
[TBL] [Abstract][Full Text] [Related]
16. The relationship between competence for secretion of H2O2 and completion of tumor cytotoxicity by BCG-elicited murine macrophages.
Cohen MS; Taffet SM; Adams DO
J Immunol; 1982 Apr; 128(4):1781-5. PubMed ID: 7061849
[TBL] [Abstract][Full Text] [Related]
17. Tumoricidal effector mechanisms of murine BCG-activated macrophages. I. Parameters of production and initial characterization of a cytolytic factor serologically related to necrosin.
Klostergaard J; Foster WA; Leroux ME
J Biol Response Mod; 1987 Jun; 6(3):313-30. PubMed ID: 3298554
[TBL] [Abstract][Full Text] [Related]
18. Generation of anti-MOPC-315 cytotoxicity in uneducated or in vitro educated spleen cells from normal or MOPC-315 tumor-bearing mice pretreated in vivo with Bacillus Calmette-Guérin.
Braun DP; Mokyr MB; Dray S
Cancer Res; 1978 Jun; 38(6):1626-32. PubMed ID: 647676
[TBL] [Abstract][Full Text] [Related]
19. Inducible macrophage cytotoxins. I. Biokinetics of activation and release in vitro.
Reidarson TH; Levy WE; Klostergaard J; Granger GA
J Natl Cancer Inst; 1982 Oct; 69(4):879-87. PubMed ID: 6956764
[TBL] [Abstract][Full Text] [Related]
20. A cytokinetic analysis of bacillus calmette-guérin-induced growth control of a murine leukemia.
Olsson L; Mathé G
Cancer Res; 1977 Jun; 37(6):1743-9. PubMed ID: 322860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
